contact microarray printer smartarrayer 136 (CapitalBio Corporation)
90
Structured Review
CapitalBio Corporation
contact microarray printer smartarrayer 136
Contact Microarray Printer Smartarrayer 136, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/contact+printer/contact+microarray+printer+smartarrayer+136/pm40249703-755-24-29
Average 90 stars, based on 1 article reviews
Contact Microarray Printer Smartarrayer 136, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/contact+printer/contact+microarray+printer+smartarrayer+136/pm40249703-755-24-29
Average 90 stars, based on 1 article reviews
contact microarray printer smartarrayer 136 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity. Article Snippet: Article Article Title: Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity. Article Snippet: .. Each compound was dissolved in DMSO to a concentration of 10 mM and printed in duplicate on home-made phenyl-isocyanate functionalized slide with a Article Title: P53 upregulation by USP7-engaging molecular glues. Article Snippet: .. Each compound was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mmol/L and printed in duplicate along a vertical direction on homemade phenyl-isocyanate functionalized glass slides with a Microarray:Article Title: Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity. Article Snippet: Article Article Title: Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity. Article Snippet: .. Each compound was dissolved in DMSO to a concentration of 10 mM and printed in duplicate on home-made phenyl-isocyanate functionalized slide with a Article Title: P53 upregulation by USP7-engaging molecular glues. Article Snippet: .. Each compound was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mmol/L and printed in duplicate along a vertical direction on homemade phenyl-isocyanate functionalized glass slides with a Article Title: R406 and its structural analogs reduce SNCA/α-synuclein levels via autophagic degradation. Article Snippet: .. Each compound was printed twice in a vertical direction on homemade glass slides functionalized with phenyl-isocyanate using a Variant Assay:Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays. Article Snippet: In Brief Owing to the ongoing mutations of SARS-CoV-2, we developed an up-to-date CoVariant protein microarray to profile the humoral immunity.. We collected plasmas from healthy subjects who underwent two doses of matching (AZD1222 ×2 or mRNA-1273 ×2) and two doses of mixing (AZD1222 + mRNA1273).. We found that mixing generates more surrogate neutralizing activity against gamma and omicron than matching. Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays Article Snippet: .. A Control:Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays. Article Snippet: In Brief Owing to the ongoing mutations of SARS-CoV-2, we developed an up-to-date CoVariant protein microarray to profile the humoral immunity.. We collected plasmas from healthy subjects who underwent two doses of matching (AZD1222 ×2 or mRNA-1273 ×2) and two doses of mixing (AZD1222 + mRNA1273).. We found that mixing generates more surrogate neutralizing activity against gamma and omicron than matching. Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays Article Snippet: .. A Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Membrane:Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays. Article Snippet: In Brief Owing to the ongoing mutations of SARS-CoV-2, we developed an up-to-date CoVariant protein microarray to profile the humoral immunity.. We collected plasmas from healthy subjects who underwent two doses of matching (AZD1222 ×2 or mRNA-1273 ×2) and two doses of mixing (AZD1222 + mRNA1273).. We found that mixing generates more surrogate neutralizing activity against gamma and omicron than matching. Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays Article Snippet: .. A Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Saline:Article Title: Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity. Article Snippet: .. Each compound was dissolved in DMSO to a concentration of 10 mM and printed in duplicate on home-made phenyl-isocyanate functionalized slide with a Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Negative Control:Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Positive Control:Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. |